LONDON, August 8, 2016 /PRNewswire/ --

Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Manufacturers (CMOs); Analysis of Products Including Glass and Plastic Syringes, Cartridges, Pen Injectors, Autoinjectors, Safety Systems and Accessories; Assessment of Companies Specialising in Ready-to-Fill Drug Delivery Systems for Vaccines, Insulin and Biological Drugs

Pre-Filled Syringes and Related Drug Delivery - Discover Leading Companies' Revenue Potentials
How are companies in the pre-filled syringe industry performing? Visiongain's new report gives you data, analysis and discussions for producers of those drug delivery devices.

Our study lets you assess companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2026. There you see financial results, opinion, trends, opportunities and sales predictions.

That way you discover potentials of established and rising companies. Read on, please, to scan those organisations and see what their future market could be worth.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Forecasts and discussions to help you stay ahead in knowledge and authority
Our new study assesses 25 top companies - and analyses that overall industry - with sales results, revenue forecasts and growth rates. In our 230 page report you gain 86 tables, 30 charts and a research interview.

You also get qualitative analyses, including research and development. Our work lets you assess the most beneficial and lucrative applications of those drug delivery technologies. There you see opportunities for producers of medical injection devices and manufacturers of biologics, insulins and vaccines.

That way you stay ahead in knowledge of the industry and market for these medical devices, helping your influence. You explore leading developers, producers and marketers of these products:
• Plastic and glass pre-filled syringes
• Pen injectors and autoinjectors, including insulin delivery
• Related components and safety systems, including needles, shields, Luer fitments, plungers and tip caps
• Contract manufacturing organisations (CMOs) providing filling services for pre-filled injection devices (syringes and cartridges).

The following sections describe how our new investigation helps your work.

Company profiles - discover why firms succeed, also exploring their prospects
Our report profiles 25 leading companies worldwide across four segments of the pre-filled injection devices market. The content of each discussion differs, depending on the company. In general a profile contains the following information:
• Overview of the firm, showing its place in the pre-filled injection devices field
• Discussion of the company's product or service portfolio, including clients
• Analysis of the player's recent financial performance, esp. relevant sales
• Coverage of developments - e.g. acquisitions, R&D, expansions, launches and collaborations with the pharmaceutical industry
• Prospects of the company - strengths over competitors and opportunities
• Prediction of revenue for the period 2016-2026 (for 10 companies).

Our survey shows how product and service demand changed in recent years, as well as explaining how those needs can develop from 2016 - rising demand.

Prospects for leading pre-filled syringe manufacturers
Our study gives you discussions and financial analyses for developers and producers of pre-filled injection devices - these five leaders and other firms:
• Becton, Dickinson & Co. (BD)
• Gerresheimer
• Schott
• Nipro
• Ompi.

There you discover what the future holds for those medical device companies, seeing how they compare and compete. You find where the best prospects for business exist.

Suppliers and users of pre-filled injection systems will benefit from 2016. Next, our work analyses developers, producers and providers of associated technology.

Outlooks for manufacturers of pre-filled syringe components
The report shows you developments and revenue prospects for leading producers of syringe components and related accessories, including these companies:
• Aptar Stelmi
• Dätwyler Holding
• West Pharmaceutical Services.

In our study you explore opportunities for companies making injection safety systems, plungers, needle shields, caps and related products.

Our work shows you where sales growth can occur. Many opportunities remain, with expanding revenues likely from 2016 to 2026. See what is possible.

Potentials of leading pen injector and autoinjector producers
In our study you also see commercial outlooks for top manufacturers of pen injectors and autoinjectors, including these companies:
• Haselmeier
• Owen Mumford
• SHL Group
• Ypsomed.

There you assess product portfolios, strategies and revenue prospects. You also investigate associated organisations and competition. Our work shows you possibilities for advancing technologies and raising sales.

Contract manufacturers in that parenteral drug delivery
Our work also assesses contract manufacturing organisations (CMOs) in that field. There you explore these production service providers and others:
• Catalent
• Hospira One2One
• Vetter Pharma.

That way you assess the capabilities and outlooks of healthcare CMOs in that field. You also scan applications for biological drugs (biologics), lyophilisation and dual-chamber syringes, among other advances.

Value of that market in 2020 - what sales growth is possible and why?
Our analysis predicts overall world revenues for those pre-filled injection devices - the drug delivery technology - will reach $6940m in 2020. Those sales will expand further to 2026, showing strong revenue growth. Many opportunities remain.

Greater use of biologics and vaccines raise demand for parenteral delivery systems. Many opportunities exist, especially for plastic syringes, polymers and ready-to-use containment of labile drugs and other complex pharmaceuticals. Our study explains.

What about applications? Rising incidence of diabetes and expansion of the home healthcare market stimulate demand for pre-filled injection products. Explore what is possible, staying ahead. In our study you see what those companies' futures hold.

5 ways Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2016-2026 helps your work
In particular our new investigation gives you this knowledge to benefit your research, analyses, plans and presentations:
• Profiles of 25 leading companies - assess their products, technologies, activities, partnerships, developments and results
• Forecast revenue to 2026 for that overall market at world level - discover expected sales rises for pre-filled drug delivery devices and services
• Predicted revenues for top companies - see potential sales to 2026 for 10 leading participants
• Competition and opportunities - explore what affects that industry, seeing forces that influence its sales and determine its future
• Opinion from an interview with a leading company - gain insight to help you stay ahead in knowledge, benefiting your reputation for insight.

That study, by our in-house analysts in the UK, has the purpose of helping your work. There you gain data and insight you find nowhere else, to help you succeed.

Independent analysis to benefit your authority on pre-filled drug delivery
Our work gives independent analysis. There you receive business intelligence found only in that report, seeing where technological and financial prospects are most rewarding, as well as companies' potentials from 2016 to 2026.

With our study you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses and decisions, also saving time and gaining in authority. Explore that industry's future, seeing what is possible and how you can gain.

Our new investigation is for everyone assessing the industry and market for drug delivery by injection. There you find data, trends, opportunities and forecasts. Avoid missing out. Benefit in knowledge and influence by requesting our report now.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1704/Medical-Device-Leader-Series-Top-Pre-Filled-Injection-Device-Manufacturers-2016-2026

Organisations Mentioned in the Report 

AbbVie

Actavis (formerly Watson Pharmaceuticals)

AdvalTech

Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]

Albany Molecular Research (AMRI)

AluPlast

Amcor Glass Tubing (part of Nipro)

American Stelmi (part of Aptar Stelmi)

Amgen

Amylin Pharmaceuticals

Antares Pharma

Apax Partners

Aptar Stelmi (part of Aptargroup)

AptarGroup

Aptuit

AstraZeneca

B. Braun Medical

Balda Group (part of Ompi)

Baxter BioPharma Solutions (part of Baxter)

Baxter International

Bayer

BD Medico

Becton, Dickinson & Co. (BD)

Berlin-Chemie (part of Menarini Group)

Berry Plastics Group

Bespak Injectables

Biocon

Biogen Idec

Bionime

Blackstone Group

Boehringer Ingelheim

Boehringer Ingelheim BioXcellence

Bristol-Myers Squibb

Cambridge Consultants

CAPS (Central Admixture Pharmacy Services)

Cardinal Health

Cardium Therapeutics

CareFusion

Carl Zeiss Foundation

Carmel Pharma

Catalent Pharma Solutions

CeifiT

Centers for Disease Control and Prevention (CDC) [US]

Centor

Clere (part of Ompi)

Columbia Engineered Rubber

ConnectMeSmart GmbH

Consort Medical

Corning

Crucell Spain

Daikyo Seiko

Dätwyler Holding

Debiopharm Group

Diagenode

Disetronic Group (part of Roche)

Dong-A Pharmaceutical

Dr. Reddy's Laboratories

DS WorldMed

Duoject

DuPont

Elcam Medical

Eli Lilly

European Commission

European Medicines Agency (EMA)

Euticals

Federal Commission for Protection against Health Risks

Ferring Pharmaceuticals

Food and Drug Administration (FDA) [US]

Fresenius

Future Injection Technologies

Gadea Pharmaceutical Group

Genentech (part of Roche)

Genovi Pharmaceuticals Limited

Gerresheimer

Gerresheimer item (part of Gerresheimer)

GSK

Hankook Sealtech

Hanmi Pharmaceutical Co

Haselmeier

HealthPrize

HEKUMA

Hospira

Hospira One2One (part of Hospira)

Hyaluron Contract Manufacturing (HCM, part of AMRI)

Incepta Pharmaceuticals

Injectronics

Insulet

J&J

Jabil Circuit

Janssen Biotech (part of J&J)

Korea Food and Drug Administration (KFDA)

Laboratorios Farmacéuticos ROVI

LifeScan

Lupin Limited

McKesson

Medicines and Healthcare Products Regulatory Agency (MHRA) [UK]

MedImmune (part of AstraZeneca)

Medimop Medical Projects (part of West Pharmaceutical Services)

Medtronic

Menarini Group

Merck & Co.

Merck KGaA

MG Sterile Products (part of Nipro)

MGlas (part of Nipro)

Ministry of Health, Labor and Welfare (MHLW) [Japan]

Montagu Private Equity

NanoPass Technologies

Nemera

Neutral Glass and Allied Industries

Nipro

Nipro Europe (part of Nipro)

Nipro Glass (part of Nipro)

Nipro Medical (part of Nipro)

Novartis

Novo Nordisk

Nuova Ompi (Formerly Ompi, Italian part of Stevanato Group)

Nycomed (part of Takeda)

Nypro

Occupational Safety and Health Administration (OSHA) [US]

Ompi

Ompi of America (part of Stevanato Group)

Ompi of Brazil

Ompi of China

Optrel (part of Stevanato Group)

Origom

Osu Biopharmaceutical Manufacturing

Oval Medical

Owen Mumford

PA Consulting Group

Palatin Technologies

PATH

Pema Holding

Pfizer

Pharma-Pen (part of West Pharmaceutical Services)

PharmaTap

Pharmstandard

Phillips Medisize

Plastef Investissements

Polfa Tarchomin

Primequal

Revolutions Medical

Rexam

Roche

Roselabs Group

Roselabs Bioscience (part of Roselabs Group)

Roselabs Polymers (part of Roselabs Group)

ROVI CM (part of Laboratorios Farmacéuticos ROVI)

Rumpler Technologies

Safety Syringes (part of BD)

Sandoz (part of Novartis)

Sanex Packaging Connections

Sanofi

Sanofi Pasteur

Savient Pharmaceuticals

Schering-Plough (part of Merck & Co.)

Schott

Schott Kaisha

Sentry BioPharma Services

Shandong Weigao Group Medical Polymer Company

Shanghai Fosun Pharmaceutical

SHL Group

Smiths Group

Spami (part of Stevanato Group)

Square Pharmaceuticals

Stallergenes

Stelmi Asia (part of Aptar Stelmi)

Stevanato Group

Sungwon Medical

Swedish Orphan Biovitrum (Sobi)

Taisei Kako

Teva Pharmaceutical Industries

The Medical House

The Parker Institute (part of The Parker Foundation)

The Tech Group (part of West Pharmaceutical Services)

ThinFilm

tip-top

Tissue Repair Company (part of Cardium Therapeutics)

Tolmar

Tonghua Dongbao Pharmaceutical

Triveni Polymers

UCB

UK Medicines and Healthcare Products Regulatory Agency (MHRA),

Unilife

US Agency for International Development

Vetter Pharma

Weigao Group Pharmaceutical Packaging Products Company

West Company Mexico

West Pharmaceutical India Packaging Private (part of West Pharmaceutical Services)

West Pharmaceutical Services

Wockhardt

World Health Organization (WHO)

Ypsomed

Zeon Corporation

Zhongding Sealtech

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

SOURCE Visiongain Ltd